Volta Medical, a pioneering health technology company developing artificial intelligence (AI) solutions to assist electrophysiologists in assessing complex cardiac arrhythmias such as atrial ...

Creative Biogene applies advanced microbe genome editing technologies to enhance microbial strains targeting a variety of fields, including pharmaceuticals, environmental applications, and agriculture ...

Terumo Neuro, a global leader in neurovascular innovation and a wholly owned subsidiary of Terumo Corporation, today announced that their Carotid Stent System has received Premarket Approval (PMA) ...

Elisabeth Mork-Eidem, Global Chair of WFA, commented: "Each year, we see the extraordinary impact that mentorship can have, not just on individual careers but across organisations. This programme is a ...

After having your worldviews shattered by 2073, these sci-fi dystopian stories will offer different takes on similar social anxieties.

We are delighted to welcome Dr. Nicacio to the Protara team,” said Jesse Shefferman, Chief Executive Officer of Protara Therapeutics. “As a proven leader with deep expertise spanning all stages of ...

Michael Hoey admits he’s terrible at names. He used to call his kids “One, Two and Three.” When naming his startup seeking to treat a common cancer with only a few drops of water, Hoey had his ...

In the European Union (EU), lecanemab is indicated for the treatment of adult patients with a clinical diagnosis of mild cognitive impairment and mild dementia due to Alzheimer’s disease (early AD) ...

Over the past week, the media have been inundated with news of the “de-extinction” of the dire wolf (Aenocyon dirus) – a ...

Over the past week, the media have been inundated with news of the "de-extinction" of the dire wolf (Aenocyon dirus) - a ...

Vietnam is the first stop in a global PRISM conference series, with upcoming events scheduled for Athens (Greece), San Francisco, and Boston (the US). This also marks the second time the event has ...

In the European Union (EU), lecanemab is indicated for the treatment of adult patients with a clinical diagnosis of mild cognitive impairment and mild dementia due to Alzheimer's disease (early AD) wh ...